Skip to content

Triclabendazole

Egaten (triclabendazole) is a small molecule pharmaceutical. Triclabendazole was first approved as Egaten on 2019-02-13. It is used to treat fascioliasis in the USA.
Trade Name Egaten
Common Name Triclabendazole
Indication fascioliasis
Drug Class Anthelmintics (tibendazole type)
Triclabendazole
Get full access now